by | Jan 8, 2025 | Dantas, Gautam, Gorushi, Olivia, Helmink, Beth, Kwak, Suryang, Prusa, Jerome, Wallace, Miranda
— Published date: 1/9/2025
Value Proposition: Genetically engineered yeast used to treat gastrointestinal tumors through the delivery of immune checkpoint inhibitor (ICI) proteins.
Technology Description
Researchers at Washington University in St. Louis have developed a genetically engineered …
by | Dec 19, 2024 | Chou, Chun, Egawa, Takeshi
— Published Date: 12/19/2024
Value Proposition: This invention utilizes a protein to enhance T cell expansion for CAR-T cell therapy and other adoptive cellular immunotherapy.
Technology Description
Researchers at Washinton University in St. Louis have developed a mutant AP4 protein that is desig…
by | Dec 18, 2024 | Klechevsky, Eynav, Pathak, Amit, Sarker, Bapi
— Published Date: 12/19/2024
Value Proposition: New method for expanding T cells against individualized tumor-specific mutational antigens.
Technology Description
Researchers at Washington University in St. Louis have developed a device that enables high-throughput production of patient specific …
by | Oct 15, 2024 | Shea, Susan, Spinella, Philip, Thomas, Kimberly
— Value Proposition: Composition of matter that uses taurine to improve cold platelet storage shelf life and functionality.
Technology Description
Researchers at Washington University in St. Louis have developed a method to cold store platelets using taurine supplementation. There is a crucial ne…
by | Jul 18, 2024 | Kim, Brian
—
Value proposition: Novel approach to treat chronic itch through the intrathecal or intranasal delivery of JAK inhibitors.
Technology Description
Researchers at Washington University in St. Louis have developed a new method for treating chronic idiopathic pruritus (CIP) in both patients and m…